Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany 2020-01-16 10:39
WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases 2020-01-09 17:10
WuXi Biologics Congratulates OncoImmune on FDA Clearance of IND Application for Next Generation anti-CTLA-4 Antibody ONC-392 2020-01-02 08:08
WuXi Biologics Receives "Special Award to Investors in Ireland" from Asia Matters 2019-12-23 16:26
WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland 2019-11-23 01:55
WuXi Biologics Reports Outstanding Interim Results 2019-08-19 22:09
WuXi Biologics to Expand Integrated Biologics Conjugation Solution Center to Include Commercial Manufacturing 2019-06-21 08:39
WuXi Biologics Signed Letter of Intent for Long-Term Vaccine Manufacturing Contract 2019-05-21 07:30
WuXi Biologics Commenced Construction of a 48,000 L Integrated Manufacturing Center for Innovative Biologics in Chengdu 2019-05-16 15:39
WuXi Biologics Successfully Completed First FDA Routine GMP Inspection 2019-04-17 09:14
WuXi Biologics and I-Mab Biopharma Announce Long-term Strategic Manufacturing Partnership for Five Clinical and One Commercial Programs 2019-04-16 20:00
WuXi Biologics and NBE-Therapeutics Announce Comprehensive ADC Development and Manufacturing Partnership 2019-04-09 08:36
WuXi Biologics Wins 2019 CMO Leadership Awards in All Six Core Categories 2019-04-03 20:06
WuXi Biologics Receives "Asia's Best CMO of 2018" Award from IMAPAC 2019-03-26 08:24
WuXi Biologics Receives EMA GMP Certificates 2019-03-20 08:07
WuXi Biologics Continues to Deliver Record Results 2019-03-18 22:25
WuXi Biologics Congratulates Amicus on Receiving FDA Breakthrough Therapy Designation for AT-GAA 2019-02-28 09:52
ABL Bio Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Novel Immune Check Point Bispecifics for $220 Million 2019-02-26 08:23
EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo (TM) at WuXi Biologics 2019-02-19 14:21
EMA Completed Pre-Approval Inspection of cGMP DS and DP Facilities for Trogarzo(TM) at WuXi Biologics 2019-02-19 08:21
1 4 5 6 7 8 9